BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28751474)

  • 21. HIV and AIDS in Africa: good news and bad news.
    Cumming RG
    Med J Aust; 2012 Mar; 196(5):309. PubMed ID: 22432659
    [No Abstract]   [Full Text] [Related]  

  • 22. Estimate of infant HIV-free survival at 6 to 8 weeks of age due to maternal antiretroviral prophylaxis in Sub-Saharan Africa, 2004-2005.
    Boeke CE; Jackson JB
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(3):133-40. PubMed ID: 18460695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triple-combination antiretroviral therapy in sub-Saharan Africa.
    Hogg RS; Anis A; Weber AE; O'Shaughnessy MV; Schechter MT
    Lancet; 1997 Nov; 350(9088):1406. PubMed ID: 9365484
    [No Abstract]   [Full Text] [Related]  

  • 24. [Access to treatment of HIV/AIDS in the South: the challenges of sustainability].
    Kazatchkine M; Moatti JP
    Med Sci (Paris); 2008 Dec; 24(12):1007-8. PubMed ID: 19116101
    [No Abstract]   [Full Text] [Related]  

  • 25. HIV epidemic continues to make major inroads in sub-Saharan Africa. AIDS deaths estimated at 2.4 million.
    AIDS Alert; 2006 Jan; 21(1):suppl 1-3. PubMed ID: 16475246
    [No Abstract]   [Full Text] [Related]  

  • 26. Partnering for effective HIV/AIDS palliative care in sub-Saharan Africa.
    Mastrojohn J; Nanney Shelley Smith E; DiSorbo P
    Int J Palliat Nurs; 2009 Dec; 15(12):576-8. PubMed ID: 20081735
    [No Abstract]   [Full Text] [Related]  

  • 27. Inequalities in health: access to treatment for HIV/AIDS.
    Giuliano M; Vella S
    Ann Ist Super Sanita; 2007; 43(4):313-6. PubMed ID: 18209264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [HIV-treatment in Denmark and Africa--a world of differences].
    Ullum H; Søndergaard SR; Skinhøj P
    Ugeskr Laeger; 2000 Aug; 162(35):4641-3. PubMed ID: 10986888
    [No Abstract]   [Full Text] [Related]  

  • 29. Tackling India's HIV epidemic: lessons from Africa.
    Potts M; Walsh J
    BMJ; 2003 Jun; 326(7403):1389-92. PubMed ID: 12816832
    [No Abstract]   [Full Text] [Related]  

  • 30. Improving access to treatment for HIV in sub-Saharan Africa.
    Bautista-Arredondo S; Wirtz VJ; Bertozzi SM
    BMJ; 2010 Dec; 341():c6546. PubMed ID: 21123343
    [No Abstract]   [Full Text] [Related]  

  • 31. In the shadow of HIV/AIDS: forgotten diseases in sub-Saharan Africa: global health issues and funding agency responsibilities.
    Lemoine M; Girard PM; Thursz M; Raguin G
    J Public Health Policy; 2012 Nov; 33(4):430-8. PubMed ID: 22895470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.
    Boender TS; Hoenderboom BM; Sigaloff KC; Hamers RL; Wellington M; Shamu T; Siwale M; Labib Maksimos EE; Nankya I; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Ondoa P; Rinke de Wit TF
    Clin Infect Dis; 2015 Dec; 61(11):1749-58. PubMed ID: 26240203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?
    Chien CV
    PLoS One; 2007 Mar; 2(3):e278. PubMed ID: 17372625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AIDS care and treatment in Sub-Saharan Africa: implementation ethics.
    Rennie S; Behets F
    Hastings Cent Rep; 2006; 36(3):23-31. PubMed ID: 16776020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delivery of antiretroviral therapy in sub-saharan Africa.
    Weller I
    Clin Infect Dis; 2006 Sep; 43(6):777-8. PubMed ID: 16912955
    [No Abstract]   [Full Text] [Related]  

  • 36. Balancing pills and patents: intellectual property and the HIV/AIDS crisis.
    Nderitu T
    E Law; 2001 Sep; 8(3):E5. PubMed ID: 16903022
    [No Abstract]   [Full Text] [Related]  

  • 37. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa.
    Sutcliffe CG; van Dijk JH; Bolton C; Persaud D; Moss WJ
    Lancet Infect Dis; 2008 Aug; 8(8):477-89. PubMed ID: 18652994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The HIV pandemic in the year 2007, an overview].
    Bartelsman M; Veeken H
    Ned Tijdschr Geneeskd; 2007 Dec; 151(48):2655-60. PubMed ID: 18179081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic costs of HIV/AIDS prevention activities in sub-Saharan Africa.
    Kumaranayake L; Watts C
    AIDS; 2000; 14 Suppl 3():S239-52. PubMed ID: 11086868
    [No Abstract]   [Full Text] [Related]  

  • 40. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria.
    Hotez PJ; Molyneux DH; Fenwick A; Ottesen E; Ehrlich Sachs S; Sachs JD
    PLoS Med; 2006 Jan; 3(5):e102. PubMed ID: 16435908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.